Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: A relevant ex vivo model of liver infection

被引:33
作者
Lagaye, Sylvie [1 ]
Shen, Hong [1 ]
Saunier, Bertrand [1 ]
Nascimbeni, Michelina [1 ]
Gaston, Jesintha [1 ]
Bourdoncle, Pierre
Hannoun, Laurent [2 ]
Massault, Pierre-Philippe [3 ]
Vallet-Pichard, Anais [1 ,4 ]
Mallet, Vincent [1 ,4 ]
Pol, Stanislas [1 ,4 ]
机构
[1] Univ Paris 05, UMR S1016, Equipe Cycle Cellulaire Regenerat & Hepatopathies, Inst Cochin,INSERM,U1016,CNRS,UMR8104, F-75014 Paris, France
[2] Grp Hosp La Pitie Salpetriere, AP HP, Serv Chirurg Digest & Hepato Bilio Pancreat, Paris, France
[3] Hop Hotel Dieu, Grp Hosp Cochin, AP HP, Serv Chirurg Viscerale, Paris, France
[4] Hop Hotel Dieu, Grp Hosp Cochin, AP HP, Unite Hepatol, Paris, France
关键词
HUMAN HEPATOCYTES; CORE PROTEIN; SIGNALING PATHWAYS; CELL-CULTURE; IN-VITRO; EXPRESSION; MICE;
D O I
10.1002/hep.25738
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The development of human cultured hepatitis C virus (HCV) replication-permissive hepatocarcinoma cell lines has provided important new virological tools to study the mechanisms of HCV infection; however, this experimental model remains distantly related to physiological and pathological conditions. Here, we report the development of a new ex vivo model using human adult liver slices culture, demonstrating, for the first time, the ability of primary isolates to undergo de novo viral replication with the production of high-titer infectious virus as well as Japanese fulminant hepatitis type 1, H77/C3, and Con1/C3. This experimental model was employed to demonstrate HCV neutralization or HCV inhibition, in a dose-dependent manner, either by cluster of differentiation 81 or envelope protein 2specific antibodies or convalescent serum from a recovered HCV patient or by antiviral drugs. Conclusion: This new ex vivo model represents a powerful tool for studying the viral life cycle and dynamics of virus spread in native tissue and also allows one to evaluate the efficacy of new antiviral drugs. (HEPATOLOGY 2012;56:861872)
引用
收藏
页码:861 / 872
页数:12
相关论文
共 50 条
  • [41] Regulation of T cell recruitment and inflammation in the human immunodeficiency virus/hepatitis C virus coinfected liver
    Nguyen, Nam
    Hampartzoumian, Taline
    Cameron, Barbara
    Palmer, Clovis
    O'Toole, Sandra
    Post, Jeffrey
    Zekry, Amany
    Lloyd, Andrew
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (07) : 1535 - 1543
  • [42] Activation of Intrinsic Immune Responses and Microglial Phagocytosis in an Ex Vivo Spinal Cord Slice Culture Model of West Nile Virus Infection
    Quick, Eamon D.
    Leser, J. Smith
    Clarke, Penny
    Tyler, Kenneth L.
    JOURNAL OF VIROLOGY, 2014, 88 (22) : 13005 - 13014
  • [43] Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model: Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages
    Bility, Moses T.
    Cheng, Liang
    Zhang, Zheng
    Luan, Yan
    Li, Feng
    Chi, Liqun
    Zhang, Liguo
    Tu, Zhengkun
    Gao, Yanhang
    Fu, Yangxin
    Niu, Junqi
    Wang, Fusheng
    Su, Lishan
    PLOS PATHOGENS, 2014, 10 (03)
  • [44] Optimized HepaRG is a suitable cell source to generate the human liver chimeric mouse model for the chronic hepatitis B virus infection
    Yuan, Lunzhi
    Liu, Xuan
    Zhang, Liang
    Zhang, Yali
    Chen, Yao
    Li, Xiaoling
    Wu, Kun
    Cao, Jiali
    Hou, Wangheng
    Que, Yuqiong
    Zhang, Jun
    Zhu, Hua
    Yuan, Quan
    Tang, Qiyi
    Cheng, Tong
    Xia, Ningshao
    EMERGING MICROBES & INFECTIONS, 2018, 7
  • [45] A New Cell Culture System for Infection with Hepatitis B Virus that Fuses HepG2 Cells with Primary Human Hepatocytes
    Jiang, Y.
    Wang, A. H.
    Shao, L. H.
    Wang, G.
    Yao, Y. Y.
    Sai, L. T.
    Chen, F. Z.
    Zheng, F.
    Li, Y.
    Ma, L. X.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2009, 37 (03) : 650 - 661
  • [46] Liver X receptors agonists impede hepatitis C virus infection in an Idol-dependent manner
    Zeng, Jing
    Wu, Yang
    Liao, Qingjiao
    Li, Lixia
    Chen, Xinwen
    Chen, Xulin
    ANTIVIRAL RESEARCH, 2012, 95 (03) : 245 - 256
  • [47] Lymphocyte subset characterization associated with persistent hepatitis C virus infection and subsequent progression of liver fibrosis
    Yoshida, Kengo
    Ohishi, Waka
    Nakashima, Eiji
    Fujiwara, Saeko
    Akahoshi, Masazumi
    Kasagi, Fumiyoshi
    Chayama, Kazuaki
    Hakoda, Masayuki
    Kyoizumi, Seishi
    Nakachi, Kei
    Hayashi, Tomonori
    Kusunoki, Yoichiro
    HUMAN IMMUNOLOGY, 2011, 72 (10) : 821 - 826
  • [48] Viral genotype correlates with distinct liver gene transcription signatures in chronic hepatitis C virus infection
    Robinson, Mark W.
    Aranday-Cortes, Elihu
    Gatherer, Derek
    Swann, Rachael
    Liefhebber, Jolanda M. P.
    Filipe, Ana Da Silva
    Sigruener, Alex
    Barclay, Stephen T.
    Mills, Peter R.
    Patel, Arvind H.
    McLauchlan, John
    LIVER INTERNATIONAL, 2015, 35 (10) : 2256 - 2264
  • [49] Expression of MicroRNA miR-122 Facilitates an Efficient Replication in Nonhepatic Cells upon Infection with Hepatitis C Virus
    Fukuhara, Takasuke
    Kambara, Hiroto
    Shiokawa, Mai
    Ono, Chikako
    Katoh, Hiroshi
    Morita, Eiji
    Okuzaki, Daisuke
    Maehara, Yoshihiko
    Koike, Kazuhiko
    Matsuura, Yoshiharu
    JOURNAL OF VIROLOGY, 2012, 86 (15) : 7918 - 7933
  • [50] A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo
    Desombere, Isabelle
    Mesalam, Ahmed Atef
    Urbanowicz, Richard A.
    Van Houtte, Freya
    Verhoye, Lieven
    Keck, Zhen-Yong
    Farhoudi, Ali
    Vercauteren, Koen
    Weening, Karin E.
    Baumert, Thomas F.
    Patel, Arvind H.
    Foung, Steven K. H.
    Ball, Jonathan
    Leroux-Roels, Geert
    Meuleman, Philip
    ANTIVIRAL RESEARCH, 2017, 148 : 53 - 64